| AI | Artificial intelligence |
| ABVD | Adriamycin (doxorubicin), Bleomycin, Vinblastine, Dacarbazine |
| A-HIPI | Advanced-stage Hodgkin Lymphoma International Prognostic Index |
| ASCT | Autologous stem-cell transplantation |
| cHL | Classic Hodgkin lymphoma |
| ctDNA | Circulating tumor DNA |
| EBV | Epstein–Barr virus |
| GVD | Gemcitabine, vinorelbine, liposomal doxorubicin |
| HRS | Hodgkin and Reed–Sternberg |
| ICC | International Consensus Classification |
| IPS | International Prognostic Score |
| LMP1 | Latent membrane protein 1 |
| MDSC | Myeloid-derived suppressor cell |
| MRD | Minimal residual disease |
| MTAP | Methylthioadenosine phosphorylase |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NMF | Non-negative matrix factorization |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| PFS | Progression-free survival |
| TAMs | Tumor-associated macrophages |
| TARC | Thymus and Activation-Regulated Chemokine |
| TMTV | Total metabolic tumor volume |
| TME | Tumor microenvironment |
| Tpex | Progenitor exhausted T cells |
| Tregs | Regulatory T cells |
| WHO | World Health Organization |